GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Acutaas Chemicals Ltd

Acutaas Chemicals Board Approves Q2 FY27 Standalone & Consolidated Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 27 Oct 2026, 12:40 PM IST  ·  BSE ID: aab66990-5f7c-4b1f-aba5-0336f55fffec
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has approved its financial performance report for the second quarter and first half of the current financial year.
🤖 AI Summary
  • Acutaas Chemicals Board approved Unaudited Standalone and Consolidated Financial Results for Q2 FY27.
  • The results cover the second quarter and half year ended September 30, 2026.
  • Audit Committee reviewed and recommended the financial results to the Board.
  • M/s Maheshwari & Co., Chartered Accountants, issued the Limited Review Report.
  • The Board Meeting commenced at 11:30 A.M. and concluded at 2:35 P.M.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this administrative filing.
👤
Who Is Affected
All shareholders are affected as the company has formally approved and will disseminate its Q2 FY27 financial performance, impacting their understanding of company value.
🔍
Management Signal
The decision to approve results signals adherence to regulatory disclosure timelines and corporate governance processes by the management.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Acutaas Chemicals detailed financial statements for Q2 FY27 — review specific numbers.
Press release accompanying detailed results — for management commentary.
Analyst calls or investor presentations — for further insights into performance.
LOW RISK This filing is an administrative announcement of results approval, not introducing new risks.
💡 Investor Takeaway
Acutaas Chemicals Ltd Board of Directors approved the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2026, on October 27, 2026. This administrative step formalizes the Q2 FY27 results.
📅 Company Track Record
Acutaas Chemicals' Q2 FY27 PAT was reported up 71.4% YoY to ₹1,231mn (consolidated) and standalone net profit rose 17.63% YoY to Rs. 8,573.85 Lakhs (Q2 FY27). Q1 FY27 consolidated net profit was Rs. 7,497.24 lakhs, up 68.30% YoY.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What financial period do the approved results for Acutaas Chemicals cover?
The approved results cover the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2026.
Which committee reviewed the financial results before Board approval for Acutaas Chemicals?
The financial results were reviewed and recommended by the Audit Committee before presentation to the Board of Directors.
Who issued the Limited Review Report for Acutaas Chemicals' Q2 FY27 results?
The Limited Review Report for Acutaas Chemicals' Q2 FY27 results was issued by M/s Maheshwari & Co., Chartered Accountants.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.